Cystic Fibrosis Global Clinical Trials Review, H1, 2019

GlobalData's clinical trial report, “Cystic Fibrosis Global Clinical Trials Review, H1, 2019" provides an overview of Cystic Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystic Fibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Vertex Pharmaceuticals Inc

Cystic Fibrosis Foundation

Galapagos NV

Novartis AG

Gilead Sciences Inc

F. Hoffmann-La Roche Ltd

Merck & Co Inc

C. H. Boehringer Sohn ...

Vertex Pharmaceuticals Inc

Cystic Fibrosis Foundation

Galapagos NV

Novartis AG

Gilead Sciences Inc

F. Hoffmann-La Roche Ltd

Merck & Co Inc

C. H. Boehringer Sohn AG & Co KG

Allergan Plc

Proteostasis Therapeutics Inc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region ...

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Cystic Fibrosis to Respiratory Clinical Trials 17

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Cystic Fibrosis to Respiratory Clinical Trials 21

Clinical Trials by Phase in E7 Countries 22

Clinical Trials in E7 Countries by Trial Status 23

Clinical Trials by Phase 24

In Progress Trials by Phase 25

Clinical Trials by Trial Status 26

Clinical Trials by End Point Status 28

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Cystic Fibrosis Therapeutics Clinical Trials 33

Prominent Drugs 35

Latest Clinical Trials News on Cystic Fibrosis 36

Apr 23, 2019: AzurRx BioPharma exceeds 50% enrollment target for Phase II OPTION clinical trial 36

Apr 23, 2019: Synspira Therapeutics SNSP 113 demonstrates improvement in Abnormal Cystic Fibrosis Mucus and Pulmonary Disease 36

Apr 15, 2019: Abeona Therapeutics to present data for ABO-401 in Cystic Fibrosis and Retinal Disorders at the American Society of Gene and Cell Therapy Annual Meeting 37

Apr 01, 2019: Savara initiates phase 2a clinical study of Molgradex for the treatment of NTM lung infection in people living with cystic fibrosis 37

Mar 27, 2019: Eloxx Pharmaceuticals presents positive new data for lead investigational drug, ELX-02, at the European Cystic Fibrosis Society (ECFS) Basic Science Conference 37

Mar 25, 2019: Proteostasis Therapeutics announces broad new dataset from proprietary combination and add-on CFTR modulator studies in cystic fibrosis patients 38

Mar 18, 2019: AzurRx BioPharma announces presentation on its positive phase II data in MS1819-SD in chronic pancreatitis at the 2019 Digestive Disease Week Conference 39

Mar 12, 2019: AzurRx BioPharma announces poster presentation at the Americas Hepato-Pancreato-Biliary Association 2019 Annual Meeting 40

Mar 06, 2019: Vertex reports preliminary data for triple combination cystic fibrosis therapy 40

Feb 21, 2019: Calithera Biosciences initiates phase 1 trial of arginase inhibitor CB-280 for the treatment of cystic fibrosis 41

Feb 20, 2019: AzurRx BioPharma announces first patients dosed in phase II OPTION clinical trial 41

Feb 14, 2019: Positive phase 3 study for Tezacaftor/Ivacaftor combination in children aged 6-11 years with cystic fibrosis supports European Medicines Agency submission 42

Clinical Trial Profile Snapshots 43

Appendix 575

Abbreviations 575

Definitions 575

Research Methodology 576

Secondary Research 576

About GlobalData 577

Contact Us 577

Source 578

List of Tables

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Region, 2019* 8

Cystic Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Cystic ...

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Region, 2019* 8

Cystic Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Cystic Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12

Cystic Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13

Cystic Fibrosis Therapeutics Clinical Trials, North America, Top Countries, 2019* 14

Cystic Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 15

Cystic Fibrosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16

Proportion of Cystic Fibrosis to Respiratory Clinical Trials, G7 Countries (%), 2019* 17

Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18

Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19

Proportion of Cystic Fibrosis to Respiratory Clinical Trials, E7 Countries (%), 2019* 21

Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22

Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Phase, 2019* 24

Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 25

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26

Cystic Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28

Cystic Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29

Cystic Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 30

Cystic Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 31

Cystic Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 33

Cystic Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35

List of Figures

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Cystic Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Cystic ...

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Cystic Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Cystic Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12

Cystic Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13

Cystic Fibrosis Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14

Cystic Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 15

Cystic Fibrosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16

Proportion of Cystic Fibrosis to Respiratory Clinical Trials, G7 Countries (%), 2019* 17

Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18

Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19

Proportion of Cystic Fibrosis to Respiratory Clinical Trials, E7 Countries (%), 2019* 21

Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22

Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Phase (%), 2019* 24

Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 25

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26

Cystic Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28

Cystic Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29

Cystic Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 30

Cystic Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 31

Cystic Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 33

Cystic Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35

GlobalData Methodology 576

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports